Submissions for IDA 2024 are now closed. Finalize your entries by December 8, 2024.
Picodya's B-Matrix™ is an innovative In-Vitro diagnostics platform that allows quick and affordable laboratory-grade diagnostics at the point-of-care
B-Matrix is used in clinics, hospitals, research institutes, and vehicles and saves time for sending tests to central labs. It tests respiratory diseases including COVID19, Infectious disease, cardio, and more. The matrix technology of the product allows tests for several patients in parallel, resulting in higher throughputs and lower cost per test compared to other solutions.